GenomeScan is partnering with Olink Proteomics to bring proteomics to the next level by enabling high-throughput analysis of thousands of proteins, while using less than a drop of blood.
Olink’s PEA technology that is based on dual antibody recognition results in the coupling of DNA oligonucleotides and boasts exceptional levels of specificity, sensitivity and dynamic range.
By combining different omics approaches, GenomeScan helps facilitates researchers in identifying the regulators of biological processes, identifying new targets for drug discovery, evaluating therapeutic interventions, and identifying biomarkers that can be used for diagnosis, prognosis, and disease monitoring, leading to more precise and effective treatments.
Dura Vermeer Commercieel Vastgoed and Cellares has signed a long-term lease for a new IDMO Smart Factory in building Nexus (9,741 sqm LFA) at Leiden Bio Science Park. The...
The successful program for stimulating digitization in small and medium-sized businesses in the Leiden and Katwijk region is getting a sequel. Key Region Leiden, in cooperation...
Leiden, 8 January 2026 – Two scientific projects from Leiden University and LUMC have received funding from Open Science NL. The aim is to make science more accessible to...